Positive correlation of serum bio-intact PTH(1-84) but not intact PTH with parathyroid gland size in hemodialysis patients

Biomedicine and Pharmacotherapy

Volumn 60, Issue 2, 2006, Pages 62-65

  Inaba, Masaaki ^a   Okuno, Senji ^b   Chou, Hidenori ^a   Imanishi, Yasuo ^a   Ueda, Misako ^a   Yamakawa, Tomoyuki ^b   Ishimura, Eiji ^a   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Shirasagi Hospital   (Japan)

Author keywords

Bone marker; Bone turnover; Chronic renal failure; Hemodialysis; PTH

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; OSTEOCALCIN; PARATHYROID HORMONE DERIVATIVE; PTH[1-84]; PYRIDINOLINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE TURNOVER; CALCIUM BLOOD LEVEL; CELL SIZE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; HEMODIALYSIS; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; MALE; OSSIFICATION; OSTEOLYSIS; PARATHYROID FUNCTION; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SERUM GROUP PI SYSTEM;

ALKALINE PHOSPHATASE; BONE AND BONES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROID HORMONE; RENAL DIALYSIS;

EID: 33644919134     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2005.11.001     Document Type: Article

References (18)

1. R. Lepage, L. Roy, J.H. Brossard, L. Rousseau, C. Dorais, and C. Lazure A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples Clin. Chem. 44 1998 805 809
2. M. Inaba, K. Nakatsuka, Y. Imanishi, M. Watanabe, Y. Mamiya, and E. Ishimura Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone Clin. Chem. 50 2004 385 390
3. J.H. Brossard, R. Lepage, H. Cardinal, L. Roy, L. Rousseau, and C. Dorais Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays Clin. Chem. 46 2000 697 703
4. J.H. Brossard, M. Cloutier, L. Roy, R. Lepage, M. Gascon-Barre, and P. D'Amour Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values J. Clin. Endocrinol. Metab. 81 1996 3923 3929
5. M. Inaba, S. Okuno, Y. Imanishi, M. Ueda, T. Yamakawa, and E. Ishimura Significance of bio-PTH(1-84) assay in hemodialysis patients Osteoporos Int. 16 5 2005 517 525
6. M.C. Langub, M.C. Monier-Faugere, G. Wang, J.P. Williams, N.J. Koszewski, and H.H. Malluche Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure Endocrinology 144 2003 1135 1138
7. S. Okuno, E. Ishimura, K. Kitatani, H. Chou, K. Nagasue, and K. Maekawa Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism Nephrol. Dial. Transplant. 18 2003 2613 2621
8. Y. Kumeda, M. Inaba, H. Tahara, Y. Kurioka, T. Ishikawa, and H. Morii Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism J. Clin. Endocrinol. Metab. 85 2000 4157 4161
9. B. Gomez Jr., S. Ardakani, J. Ju, D. Jenkins, M.J. Cerelli, and G.Y. Daniloff Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum Clin. Chem. 41 1995 1560 1566
10. M. Inaba, Y. Nishizawa, K. Mita, Y. Kumeda, M. Emoto, and T. Kawagishi Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes Osteoporos. Int. 9 1999 525 531
11. M. Ueda, M. Inaba, S. Okuno, K. Nagasue, K. Kitatani, and E. Ishimura Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients Am. J. Kidney Dis. 40 2002 802 809
12. M. Inaba, K. Nagasue, S. Okuno, M. Ueda, Y. Kumeda, and Y. Imanishi Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus Am. J. Kidney Dis. 39 2002 1261 1269
13. Y. Furumitsu, M. Inaba, K. Yukioka, M. Yukioka, Y. Kumeda, and Y. Azuma Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis J. Rheumatol. 27 2000 64 70
14. R. Okabe, K. Nakatsuka, M. Inaba, T. Miki, H. Naka, and H. Masaki Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-tlopeptides Clin. Chem. 47 2001 1410 1414
15. L. Nguyen-Yamamoto, L. Rousseau, J.H. Brossard, R. Lepage, P. Gao, and T. Cantor Origin of parathyroid hormone (PTH) fragments detected by intact-PTH assays Eur. J. Endocrinol. 147 2002 123 131
16. J. Bover, A. Jara, P. Trinidad, M. Rodriguez, and A.J. Felsenfeld Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus Bone 25 1999 279 285
17. J.J. Kazama, T. Shigematsu, K. Yano, E. Tsuda, M. Miura, and Y. Iwasaki Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure Am. J. Kidney Dis. 39 2002 525 532
18. S. Fletcher, R.G. Jones, H.C. Rayner, P. Harnden, L.D. Hordon, and J.E. Aaron Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology Nephron 75 1997 412 419